| NP0333100 | Talarolide B | |  | C35H55N7O8
701.8660 Da 701.41121 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0333101 | Talarolide C | |  | C34H53N7O9
703.8380 Da 703.39048 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0333102 | Wulfenioidin M | |  | C22H29NO2
339.4790 Da 339.21983 Da | | 1H NMR Spectrum (1D, 400.132184708, CDCl3, simulated) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0333103 | Talarolide D | |  | C34H53N7O9
703.8380 Da 703.39048 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) |
|
| NP0333104 | Wulfenioidin N | |  | C22H29NO
323.4800 Da 323.22491 Da | | 1H NMR Spectrum (1D, 400.152200825, CDCl3, simulated) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0333105 | 5,7,4’-trihydroxyflavone-8-α-L-rhamnopyranoside-4’-O-β-D-galactopyranosyl | |  | C27H30O14
578.5230 Da 578.16356 Da | |
| NP0333106 | OfficinalisoidA | |  | C30H46O5
486.6930 Da 486.33452 Da | |
| NP0333107 | Officinalisoid B | |  | C30H46O4
470.6940 Da 470.33961 Da | |
| NP0333108 | Officinalisoid C | |  | C30H48O4
472.7100 Da 472.35526 Da | |
| NP0333109 | Officinalisoid D | |  | C30H48O3
456.7110 Da 456.36035 Da | |
| NP0333110 | Acyl-surugamide A2 | |  | C50H83N9O9
954.2680 Da 953.63138 Da | | 1H NMR Spectrum (1D, 599.8737042, C2D6OS, simulated) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0333111 | Stevisalioside A | |  | C35H50O15
710.7700 Da 710.31497 Da | | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) |
|
| NP0333112 | Stevisalioside C | |  | C41H62O19
858.9280 Da 858.38853 Da | | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) |
|
| NP0333113 | Wulfenioidin L | |  | C22H27NO2
337.4630 Da 337.20418 Da | | 1H NMR Spectrum (1D, 600.230706647, CDCl3, simulated) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0333114 | 5-Hydroxy-4',7-dimethoxyflavone | |  | C17H16O5
300.3100 Da 300.09977 Da | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0333115 | noonazine A | |  | C19H16N2O4
336.3470 Da 336.11101 Da | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) |
|
| NP0333116 | noonazine B | |  | C19H16N2O5
352.3460 Da 352.10592 Da | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) |
|
| NP0333117 | noonazine C | |  | C19H16N2O5
352.3460 Da 352.10592 Da | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) |
|
| NP0333118 | coelomycin | |  | C18H14N2O4
322.3200 Da 322.09536 Da | |
| NP0333119 | noonaphilone A | |  | C24H20O7
420.4170 Da 420.12090 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) |
|
| NP0333120 | Bulbiferamide A | |  | C45H64N10O8
873.0690 Da 872.49086 Da | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 176 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, C2D6OS, experimental) |
|
| NP0333121 | Glucotropaeolin, potassium salt | |  | C14H19NO9S2
409.4200 Da 409.05012 Da | | 1H NMR Spectrum (1D, 300.13, D2O, simulated) | | 1H NMR Spectrum (1D, 300 MHz, D2O, experimental) | | [1H, 1H] NMR Spectrum (2D, 300 MHz, D2O, experimental) | | 13C NMR Spectrum (1D, 75 MHz, D2O, experimental) | | [1H, 13C] NMR Spectrum (2D, 300 MHz, D2O, experimental) | | 1H NMR Spectrum (1D, 300 MHz, D2O, experimental) |
|
| NP0333122 | Benderadiene | |  | C18H29BrO2
357.3320 Da 356.13509 Da | |
| NP0333123 | Strophioblin | |  | C20H24O6
360.4060 Da 360.15729 Da | |
| NP0333124 | Colletotrichindole A | |  | C17H21NO5
319.3570 Da 319.14197 Da | | 1H NMR Spectrum (1D, 400.13, C3D6O, simulated) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, C3D6O, experimental) | | 13C NMR Spectrum (1D, 101 MHz, C3D6O, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, C3D6O, experimental) | | 13C NMR Spectrum (1D, 101 MHz, C3D6O, experimental) | | 13C NMR Spectrum (1D, 101 MHz, C3D6O, experimental) | | 1H NMR Spectrum (1D, 400 MHz, C3D6O, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, C3D6O, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, C3D6O, experimental) |
|